Working with the FDA

Tools

Benefits of Meeting with FDA
Date: 7/28/2011
Length: 0 minutes
Speaker(s): Su-Mien Chong
Sources: Stanford Biodesign
Description: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA: Question 4: When and how to interact with the FDA?

Other Videos in Series

Benefits of Meeting with FDA
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA: Question 4: When and how to interact with the FDA? Watch More
Case Study: Building a Relationship
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA:
Question 8: How did you build the relationship between Acclarent and the FDA?
Watch More
Developing a Relationship with FDA
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA: Question 6: How do you develop a good relationship with the FDA?
Watch More
Downside to Meeting with FDA
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA:
Question 7: Is there a downside to meeting with the FDA?
Watch More
How Brance makes a Difference
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA: Question 3: Does branch choice make a difference at the FDA?
Watch More
Other Advice
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA:
Question 9: Do you have any other advice about working with the FDA?
Watch More
Targeting FDA Branches
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA: Question 1: How did Acclarent know which branch to target in the FDA?
Watch More
When to Interact with FDA
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA: Question 4: When and how to interact with the FDA?
Watch More
Who Companies Work with at FDA
Su-Mien Chong
7/28/2011
Summary: Paul Yock interviews Su-Mien Chong, regulatory consultant, to discuss working with the FDA: Question 2: How did Acclarent know who to work with at the FDA?
Watch More

comments powered by Disqus

Search e360TV

Stay Connected

Email Newsletter Signup

Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.

Email Newsletters

Want to be up-to-date with the latest news and updates from Entrepreneurship.org? To subscribe, just give us your email address below; you'll choose which e-newsletters you'd like to receive on the next screen.